V. R. Ros

Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images

William J. Howat, Arvydas Laurinavicius, Renaldas Augulis, 2019, Scientific Reports.

Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)

Y. Drew, S. Domchek, Young-Ae Park, 2019, Annals of Oncology.